The expression differences and their significance of the relevant receptors in breast cancer

李立立; 姜达

doi:10.3969/j.issn.1007-3969.2015.02.013

您当前的位置：

首页 >

文章列表页 >

The expression differences and their significance of the relevant receptors in breast cancer

更新时间：2025-12-31

- The expression differences and their significance of the relevant receptors in breast cancer
- China Oncology Vol. 25, Issue 2, Pages: 155-160(2015)
- 作者机构：
  
  河北医科大学第四医院肿瘤内科,河北,石家庄,050035
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2015.02.013
  CLC：
- Published Online：13 May 2015，
  
  Published：13 May 2015
- 稿件说明：
移动端阅览
李立立,姜达 . 乳腺癌的相关受体表达差异及进展[J]. 中国癌症杂志, 2015, 25(2): 155-160.

李立立, 姜达. The expression differences and their significance of the relevant receptors in breast cancer[J]. China Oncology, 2015, 25(2): 155-160.
李立立,姜达 . 乳腺癌的相关受体表达差异及进展[J]. 中国癌症杂志, 2015, 25(2): 155-160. DOI： 10.3969/j.issn.1007-3969.2015.02.013.

李立立, 姜达. The expression differences and their significance of the relevant receptors in breast cancer[J]. China Oncology, 2015, 25(2): 155-160. DOI： 10.3969/j.issn.1007-3969.2015.02.013.

摘要

ER、PR、HER-2在乳腺癌中是指导治疗和判断预后的重要的生物学标志物。随着乳腺癌的病情进展，ER、PR、HER-2的表达在原发灶及转移灶中可能存在差异。目前临床医师已意识到对转移灶进行受体检测的必要性。该文结合目前的研究现状就上述问题进行综述。

Abstract

HER-2 are significant biological markers in guiding the choice of treatment and evaluating clinical prognosis. As the progression of tumor cells

the expressions of these receptors in recurrent tumors may be ifferent from primary tumors. Nowadays clinicians have realized the necessity of receptor detection in the metastatic lesions. This article summarized the current research status on the above issues.

关键词

Keywords

references

Views

2170

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)

Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives

A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China

Impact of miR-193a-3p on migration and invasion of breast cancer stem cells through targeting TRIM14

Axillary management after neoadjuvant therapy for breast cancer and optimization of sentinel lymph node diagnosis and treatment

Related Author

The Society of Breast Cancer China Anti-Cancer Association

Breast Oncology Group of the Oncology Branch of the Chinese Medical Association

LU Ye

ZHANG Wenxiang

KONG Xiangyi

FANG Yi

WANG Jing

GAO Jidong

Related Institution

Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases

Department of Laboratory Medicine, Xingtai People’s Hospital

AI问答

⁰